ADMA BIOLOGICS, INC. Treasury Stock, Shares, Acquired
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- ADMA BIOLOGICS, INC. treasury stock, shares, acquired for the quarter ending 2025-12-31 was 590.00K shares.
- ADMA BIOLOGICS, INC. treasury stock, shares, acquired for the quarter ending 2025-09-30 was 512.00K shares.
- ADMA BIOLOGICS, INC. treasury stock, shares, acquired for the quarter ending 2024-12-31 was 0.00 shares.
- ADMA BIOLOGICS, INC. treasury stock, shares, acquired for the quarter ending 2024-09-30 was 0.00 shares.
- ADMA BIOLOGICS, INC. treasury stock, shares, acquired for fiscal 2025 was 1.92M shares.
- ADMA BIOLOGICS, INC. treasury stock, shares, acquired for fiscal 2024 was 0.00 shares.
| Period end | Treasury Stock, Shares, Acquired 3 month | Treasury Stock, Shares, Acquired 12 month |
|---|---|---|
| 2025-12-31 | 590.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 1.92M shares 10-K · filed 2026-02-25 |
| 2025-09-30 | 512.00K shares 10-Q · filed 2025-11-05 | |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 0.00 shares 10-K · filed 2026-02-25 |
| 2024-09-30 | 0.00 shares 10-Q · filed 2025-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |